Recommendations: Include vaccination against COVID-19 with bivalent vaccine in the pediatric population (from 6 months of age); Reaffirmation of the NITAG recommendation of January 2023, based on the current availability of bivalent vaccine the NITAG considers it important to prioritize it in the